Bi Asset Management Fondsmaeglerselskab A Alnylam Pharmaceuticals, Inc. Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $5.77 Billion
- Q3 2024
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 8,523 shares of ALNY stock, worth $2.14 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,523
Previous 4,562
86.83%
Holding current value
$2.14 Million
Previous $1.11 Million
111.36%
% of portfolio
0.04%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ALNY
# of Institutions
644Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$4.14 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.17 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.4 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.32 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.24 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...